LLY
56
-4
YUM
38
-2
NDAQ
48
2
MAT
52
-3
NFLX
58
-3
APH
61
-4
CVS
52
-6
SLB
46
-7
RF
51
-3
CFG
56
-2
DAL
79
-4
EXC
54
3
MMC
60
-2
CI
59
-4
PEG
46
-7
BK
77
-2
GWW
64
-7
BAX
47
-4
BWA
59
-5
R
63
-3
LLY
56
-4
YUM
38
-2
NDAQ
48
2
MAT
52
-3
NFLX
58
-3
APH
61
-4
CVS
52
-6
SLB
46
-7
RF
51
-3
CFG
56
-2
DAL
79
-4
EXC
54
3
MMC
60
-2
CI
59
-4
PEG
46
-7
BK
77
-2
GWW
64
-7
BAX
47
-4
BWA
59
-5
R
63
-3
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

Unlock the Ultimate Gold Play: $20 for a 1 Oz Stake in Gold!

Don't miss out-click here for urgent details on the #1 gold play of the year!
Sell
43

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
66.09
Seasonality Move:
12.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Multimillionaire Trader Reveals His #1 Gold Pick

Click here to learn more about this game-changing opportunity.

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 26.4% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 9 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $64.43. The Score for BIB is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 26.4% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
43
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 9 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
40.10

Prediction Charts

Market Cap:
0
Price in USD:
64.43
Volume:
13.33K
Beta:
1.83

Technical Analysis

SMA50:
64.28
SMA100:
62.76
SMA200:
59.50
52-Wk Change:
35.7%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 64.43 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-26 63.42 63.01 63.42 62.50
Sep-27 63.17 63.19 64.17 63.17
Sep-30 63.58 63.76 64.25 62.49
Oct-1 62.96 63.10 63.25 61.74
Oct-2 62.60 63.22 63.22 61.82
Oct-3 62.91 61.26 62.91 61.04
Oct-4 62.92 62.26 62.92 61.36
Oct-7 62.63 60.73 62.63 60.44
Oct-8 60.70 61.31 61.75 60.70
Oct-9 61.72 61.56 61.79 61.10
Oct-10 60.98 61.50 61.68 60.65
Oct-11 61.72 63.73 63.86 61.54
Oct-14 63.45 63.91 64.21 63.12
Oct-15 64.00 64.43 64.90 63.83

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.